Table 2.

Metabolites that exhibited different concentrations in control and IRI urine samples

			Control Mice (pre-IRI)		Study Mice (post-IRI)
Metabolite, ppm	Multiplet Structurea	P Value	Concentration, mM	SD	Concentration, mM	SD
1-Methyl-nicotinamide
4.48	s	1.77E−14	1.09E−01	2.80E−02	1.12E−02	2.36E−02	13/17 AB
8.18	m	ABb	AB	AB	AB	AB
8.89	d	1.83E−09	7.75E−02	2.53E−02	9.98E−03	2.33E−02
8.96	d	3.42E−10	8.10E−02	2.42E−02	1.79E−02	2.90E−02
9.272	s	9.28E+00	7.84E−02	3.20E−02	3.70E−02	5.89E−02
2-Oxoglutarate
2.42	t	2.38E−06	3.62E+00	1.95E+00	1.25E−01	3.55E−01	15/17 AB
2.99	t	9.15E−10	4.01E+00	2.16E+00	3.31E−02	3.58E−01
2-Oxoisocaproate
0.941	d	2.77E−12	8.53E−01	2.32E−01	AB	6.97E−02	13/17 AB
2.101	m	AB	AB	AB	3.65E−03	AB
2.617	d	2.18E−05	7.27E−01	1.74E−01	**c	1.50E−02
Cis-aconitate
3.124	m	2.62E−10	9.59E−01	1.21E−01	**	**
5.71	s	1.33E−19	9.03E−01	1.43E−01	1.98E−01	1.66E−01
Citrate
2.52	d	1.83E−07	5.84E+00	1.98E+00	3.98E+00	3.84E+00
2.65	d	1.47E−06	4.27E+00	2.06E+00	6.94E−01	3.45E+00
Creatinine
3.049	s	**	1.86E+00	6.56E−01	6.77E−01	3.36E−01
4.052	s	1.45E−19	1.74E+00	3.03E−01	**	3.20E−01
Creatinine phosphate
3.046	s	**	**	**	1.93E+00	**
3.96	s	6.80E−10	2.59E+00	4.69E−01	1.35E+00	1.07E+00
Ethanol
1.17	d	6.63E−03	1.35E+00	4.52E−01	**	9.23E−01
3.64	q	**	**	**	AB	**
Galactaric acid
3.94	s	**	**	**	**	**	8/17 AB
4.25	s	7.17E−15	1.20E+00	1.02E+00	1.19E−01	1.39E−01
Guanine
7.66	S	1.29E−09	3.49E+00	9.81E−01	1.55E−02	1.20E+00	7/17 AB
Hippurate
3.97	d	**	1.91E+00	4.00E−01	7.47E−02	6.39E−02	5/17 AB
7.551	t	1.33E−15	2.18E+00	3.95E−01	**	1.09E−01
7.638	t	**	**	**	1.25E−01	**
7.837	d	9.47E−15	2.28E+00	4.14E−01	AB	1.59E−01
8.51		AB	AB	AB	1.88E+00	AB
Malonate
3.108	s	4.98E−04	4.73E−01	1.33E−01	3.03E−01	1.49E−01
Nicotinomide-n-oxide
7.64	t	8.87E−15	**	**	AB	AB
7.74	m	**	1.97E−01	6.42E−02	AB	AB
8.12	m	1.03E−11	1.73E−01	4.67E−02	AB	AB
8.4		AB	AB	AB	AB	AB
8.49	m	4.20E−11	1.65E−01	5.02E−02	AB	AB
8.743	m	1.18E−16	1.58E−01	3.90E−02	2.53E−01	AB
n-Nitrosodimethylamine
3.161	s	5.88E−15	6.42E−01	1.14E−01	**	1.51E−01
3.803	s	6.09E−05	7.03E−01	1.45E−01	2.04E−01	**
Putrescine
1.772	m	1.19E−07	1.33E+00	8.21E−01	2.61E−01	2.57E−01
3.06	m	4.10E−04	1.08E+00	8.05E−01	2.70E−01	3.00E−01
Sarcosine
2.724	s	5.66E−14	1.01E+00	2.36E−01	**	1.36E−01
3.6	s	**	1.01E+00	1.82E−01	2.07E−01	**
Succinate
2.411	s	3.96E−09	1.79E+00	6.81E−01	2.07E−01	8.80E−02
Taurine
3.25	t	**	1.25E+01	3.42E+00	1.31E+01	5.07E+00
3.42	t	2.75E−02	1.43E+01	4.54E+00	AB	7.07E+00
Trigonelline
4.443	s	2.93E−15	4.50E−01	5.80E−02	5.42E−02	AB
8.086	t	5.92E−12	5.10E−01	7.97E−02	AB	6.46E−02
8.78		AB	AB	AB	7.23E−02	AB
8.84	dd	2.09E−20	4.49E−01	5.98E−02	AB	7.02E−02
9.0736		AB	AB	AB	7.70E−02	AB
9.125	m	2.16E−20	5.32E−01	6.84E−02	1.05E+00	6.23E−02
Trimethlyamine N-oxide
3.26	s	3.46E−11	1.79E+00	1.39E+00	1.05E+00	5.63E−01
Trimethylamine
2.88	s	1.96E−06	4.00E+00	2.15E+00	1.79E−01	3.38E−01
Uracil
5.79	d	2.88E−12	3.26E−01	8.64E−02	1.17E−01	8.05E−02
7.52	d	AB	AB	AB	AB	AB
Alanine
1.48	d	4.88E−11	8.06E−02	2.80E−02	4.44E−01	3.17E−01
3.8	q	**	**	**	**	**
Lactate
1.33	d	1.37E−11	4.08E−01	1.95E−01	1.72E+00	1.20E+00
4.1	q	**	**	**	**	**
Valine
1	d	6.12E−03	4.96E−02	1.60E−02	4.18E−01	3.16E−01
1	d	6.12E−03	AB	AB	**	3.16E−01
2.3	m	**	**	**	**	**
3.6	d	**	**	**	2.75E−01	**
Leucine
0.9	t	2.77E−12	AB	AB	**	2.02E−01
1.7	m	**	**	**	**	**
3.7	m	**	**	**	7.88E+00	**
Glucose
3.72	m	1.39E−09	**	**	7.86E+00	4.47E+00
3.82	m	8.12E−04	**	**	7.59E+00	4.20E+00
3.889	d	2.39E−06	**	**	7.78E+00	4.48E+00
4.63	d	3.21E−08	7.53E−01	4.57E−01	7.97E+00	4.48E+00
5.223	d	2.66E−08	6.37E−01	3.89E−01	7.97E+00	4.32E+00

^aNMR peak multiplet structure: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; m, complex multiplet.

^bAB indicates that the peak was absent in the spectra.

^cDouble asterisks indicate that the peaks were overlapped and a reliable P value or average concentration could not be calculated.